WOAG
WITHDRAWAL OF ATTORNEY GRANTED
01/11/2025
Back to search
Official data from USPTO
LEALING BIOPHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
LEALING BIOPHARMA
ST13
US500000090860167Class
5
Filing
90860167
Registration
6825724
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
15
Latest update
04/03/2026
Trademark type
Word
Nice classes
5
Filing date
08/02/2021
Registration date
08/23/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/23/2022
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
07/31/2021
First use in commerce
07/31/2021
Drawing code
4
Owner type
99
Owner location
Jiangsu, CN
Examiner
WUDARSKY, MINDY CHEK
Law office
T50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Liling biopharmaceuticals (Suzhou) Co., Ltd
Representatives
Liling biopharmaceuticals (Suzhou) Co., Ltd
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Immunostimulants; Biological preparations for the treatment of cancer; Biological preparations for the treatment of infectious diseases; Disinfecting wipes; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Pharmaceutical preparations and substances for the treatment of infectious diseasesblood disorderspaininflammationsepsisalopeciaobesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseasesbacteria-based diseases or disordersautoimmune diseases or disorderskidney diseases or disordersdiabetes; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseasesfor the treatment of bacteria-based diseasesfor the treatment of diabetesanti - infective preparationsantiviral preparationsantibioticsantifungal preparations and vaccines; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparationsantivirals; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseasesfor the treatment of cancer; Tumor suppressing agents
Publications
History of USPTO decisions and trademark events.
15 publications found
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
01/11/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/23/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
08/23/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/07/2022
PUBO
PUBLISHED FOR OPPOSITION
06/07/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/18/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/05/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
05/03/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/03/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
05/03/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/03/2022
DOCK
ASSIGNED TO EXAMINER
04/29/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/28/2021
NWAP
NEW APPLICATION ENTERED
08/05/2021
Continuous trademark protection
Get notified about every new filing that threatens LEALING BIOPHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.